The oral-gut axis describes the bidirectional connection between the oral and gut microbiomes. It operates through two primary pathways: direct translocation of oral bacteria into the gastrointestinal tract through swallowed saliva (approximately 1.5 litres daily), and indirect immune signaling whereby oral inflammation generates systemic immune responses that influence gut mucosal function. The relationship is bidirectional — gut microbiome dysbiosis can also alter oral microbiome composition. Kunath et al. (Nature Reviews Microbiology, 2024) identified this as a central focus in emerging microbiome science.

Yes. Published research confirms that oral bacteria can translocate to the gut through swallowed saliva. Kitamoto et al. (PMC, 2020, cited 540) demonstrated that oral pathogens including Fusobacterium nucleatum have been detected in gut microbiome samples of patients with gastrointestinal conditions. Studies have estimated that up to 45% of bacteria found in the gut may originate from the oral cavity. Under normal conditions, gastric acid limits oral bacterial colonization; in individuals with oral dysbiosis or compromised gut defenses, translocation may be higher.

Yes. Published research specifically describes gut-to-oral microbial transmission as a distinct pathway. Patients with inflammatory bowel disease frequently show altered oral microbiome profiles; some animal model research found that improving gut microbiome composition is associated with downstream changes in oral microbiome balance. This is one reason researchers increasingly describe oral and gut health as two components of the same integrated microbiome system.

The oral-gut axis is under active research investigation as a pathway in several systemic diseases. Peng et al. (Nature, 2022, cited 697) reviewed links between oral microbiome dysbiosis and cardiovascular disease, rheumatoid arthritis, colorectal cancer, and Alzheimer's disease. Xu et al. (Nature, 2025, cited 66) examined oral bacteria as contributors to cardiometabolic disease through gut-mediated mechanisms. Research is ongoing and causal mechanisms are not fully established for most disease associations.

The oral-gut axis research does not establish that taking a gut probiotic directly benefits oral health; no such claim is currently supported by clinical evidence. What the research establishes is that the gut microbiome receives and responds to oral bacterial input continuously, and that a stable, resilient gut microbiome is relevant to the overall balance of the integrated human microbiome.

†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.